Delayed chemotherapy-induced nausea is augmented by high levels of endogenous noradrenaline.

Fredrikson, MDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden. (författare)

The relation between pretreatment night-time urinary catecholamine excretion and chemotherapy-induced nausea and vomiting was studied. The first cohort included 17 women and three men with various cancer forms receiving low or moderately emetogenic chemotherapy. The second cohort included 42 women receiving cisplatinum (50 mg m-2) for ovarian cancer and ondansetron as an antiemetic (8 mg i.v. x 3 at chemotherapy and 8 mg p.o. x 3 for 5 days). Relatively higher noradrenaline, but not adrenaline, excretion was associated with an increased intensity of delayed nausea following treatment. Vomiting was not consistently related to the excretion of either catecholamine. The results indicate that noradrenaline modulates delayed nausea resulting from chemotherapy.

Hursti, T JDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden. (författare)
Steineck, GDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden. (författare)
Fürst, C JDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden. (författare)
Börjeson, Sussanne,1962-Östergötlands Läns Landsting,Linköpings universitet,Omvårdnad,Hälsouniversitetet,Onkologiska kliniken US,Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.(Swepub:liu)susbo15 (författare)
Peterson, CDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden. (författare)
Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.Omvårdnad (creator_code:org_t)

Av författaren/redakt...: Fredrikson, M; Hursti, T J; Steineck, G; Fürst, C J; Börjeson, Sussan ...; Peterson, C

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.